Towards taming the bugs to improve the drugs for breast cancer

Research output: Contribution to journalReview articlepeer-review


The identification of microbial networks that are predictive of disease progression and response to therapy will not only increase our understanding of the connection between microbiota and breast cancer, but also pave the way for the development of novel microbiota-based therapeutic interventions. The study by Di Modica and colleagues points to the existence of specific microbiota in patients with HER2þ breast cancer that can influence their response to trastuzumab. This information can potentially be used to develop novel therapeutic regimens combining fecal microbiota transplant with standard cancer therapy.

Original languageEnglish (US)
Pages (from-to)1937-1939
Number of pages3
JournalCancer Research
Issue number8
StatePublished - Apr 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Towards taming the bugs to improve the drugs for breast cancer'. Together they form a unique fingerprint.

Cite this